Log in
Pharmacology · Drugs and Prescriptions

Xylometazoline

*Xylometazoline*

Xylometazoline is an imidazole derivative medication belonging to topical alpha-2 adrenergic agonists. The drug has a pronounced vasoconstrictor effect and is used in ENT practice to facilitate nasal breathing.

Chem. groupImidazole derivative
ReceptorsPeripheral alpha-2 adrenergic receptors
FormulationSol. 0.1% 10 ml
Duration6–10 hours (depending on formulation)
RestrictionNo more than 5 days to avoid tachyphylaxis
How to write a prescription
Rp.: Sol. Xylometazolini 0,1% - 10 ml
S. По 1-3 капли в каждый носовой ход 1-3 раза в день

Alternative entries: Sol. Xylometazolini 0.05% - 10 ml; Sol. Halazolini 0.1% - 10 ml

Dosage form
Sol. 0.1% 10 ml
Administration
1–3 drops into each nasal passage 1–3 times a day
Group
Drugs regulating the functions of the peripheral nervous system
2 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Mechanism of action

As an imidazole derivative, xylometazoline selectively stimulates peripheral $\alpha_2$-adrenergic receptors located in the vessels of the nasal mucosa. Unlike the $\alpha_1$-agonist phenylephrine, topical administration of drugs in this subgroup provides a longer-lasting vasoconstrictor effect (vasoconstriction).

Pharmacological effects

Activation of the receptors leads to constriction of the nasal mucosal vessels, a decrease in its edema, and a reduction in blood flow to the venous sinuses. This provides the main therapeutic outcome—improved sinus drainage and significant relief of nasal breathing.

Test your knowledge on the topicTasks from the «Pharmacology» course bank — instant answers and explanations.

Indications for use

The drug is prescribed intranasally for symptomatic treatment of rhinitis of various etiologies accompanied by pronounced nasal congestion. A topical dosage form is used.

Side effects and risks

Failure to follow the dosage regimen leads to characteristic complications:

  • Tachyphylaxis — tolerance and weakening of the vasoconstrictor effect when used for more than 5 days.
  • Withdrawal syndrome — secondary "rebound" vasodilation and nasal congestion after discontinuation (especially pronounced with xylometazoline and oxymetazoline).
  • Systemic effect — partial absorption into the systemic circulation may lead to an increase in blood pressure (BP).

Prescription specifics and contraindications

According to the reference guide, the standard dosage is 1–3 drops in each nasal passage 1–3 times a day. The product should be used no more than 3 times a day. Due to the risk of a systemic increase in blood pressure, the drug is contraindicated in patients with hypertension and severe atherosclerosis.

Briefly: answers to topical questions

What side effects are characteristic of xylometazoline?

Xylometazoline is characterized by local and systemic side effects that occur predominantly with prolonged use.

  • Tachyphylaxis — weakening of the vasoconstrictor effect when using the drug for more than 5 days.
  • Withdrawal syndrome — secondary nasal congestion ("rebound" vasodilation) after discontinuation.
  • Rhinitis — development of medicamentosa (rebound syndrome) or atrophic rhinitis when used for longer than 5–7 days.
  • Systemic effect — increase in blood pressure due to partial absorption into the bloodstream.

What are the absolute contraindications to the use of xylometazoline?

Contraindications to the use of xylometazoline include:

  • Essential hypertension.
  • Severe atherosclerosis.
  • Pregnancy.

What formulations and concentrations of xylometazoline exist?

Xylometazoline is available in topical intranasal forms:

  • Drops — 0.1% solution, 2–3 drops.
  • Spray — 1 actuation from the dispenser.

In case of excessive rhinorrhea, a fixed combination of ipratropium bromide + xylometazoline is recommended.

How to memorize

Xylometazoline and oxymetazoline are the "dangerous duo" for rebound: do not instill for more than 5 days, otherwise you will get withdrawal syndrome!

Class and exam questions

To which chemical group does xylometazoline belong?

Xylometazoline is an imidazole derivative (unlike phenylephrine, which has a different structure).

Why should xylometazoline not be used for longer than 5 days?

Continuous use for more than 5 days leads to tachyphylaxis—rapid tolerance and a weakening of the vasoconstrictor effect.

What is withdrawal syndrome in the context of xylometazoline use?

This is the development of secondary (rebound) nasal congestion after stopping the drug, which is most pronounced specifically with xylometazoline and oxymetazoline.

Something unclear? Ask the AIThe AI tutor has read the material on "Xylometazoline" and will explain it in simple terms.

What else to study on this topic

  • Comparison of the pharmacokinetics of xylometazoline and phenylephrine
  • Differences between topical and central alpha-2 adrenergic agonists
  • Pathogenesis of tachyphylaxis with prolonged use of vasoconstrictors
  • Interaction of alpha-adrenergic agonists with antihypertensive agents
  • Management measures for medicamentosa rhinitis (withdrawal syndrome)

Master the entire topic in the «Pharmacology» course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Xylometazoline" and 5,304 more pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 116 video lessons on the subject

Other topics in the «Drugs and Prescriptions» section

The entire "Drugs and Prescription" section

Free video lessons: pharmacologyShort lessons with study notes — no registration required.

Watch lessons

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.